Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Jubilant HollisterStier launches high-speed isolator based line at Spokane facility in US
This $132 million investment brings an additional 50 per cent capacity at its Spokane manufacturing facility
Deal value increased by 320 per cent in September 2025, compared to September 2024
Three major deals contributed 79.7 per cent of the total deal value during September 2025
Novo Nordisk to launch Ozempic in India, sets stage for GLP-1 market expansion
With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…
Trump imposes 100 per cent tariff on patented drugs; impact on India to be limited
Industry experts weigh in on the latest tariff move. They highlight limited near-term disruption but caution about long-term risks…
Vidal Health and SII collaborate on HPV vaccine access
Digital health programme on Vidal Health’s platform will offer an end-to-end, convenient and cashless experience, making HPV…
Merck appoints Kai Beckmann as Chair of Executive Board and CEO
He will succeed Belén Garijo, and take charge from May 1, 2026
Lupin gets tentative US FDA nod for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets
They are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least…
FDA’s curb on overseas cell processing to hit smaller cell and gene therapy companies:…
Regulators haven’t specified how many trials are affected, though therapies like CAR-T, which sometimes use overseas manufacturing…
Alembic Pharma gets EIR for its API – I & API – II facility located at Panelav
USFDA had carried out the inspection between May 26 – May 31, 2025
Shree Ramkrishna Exports Group launches Kriam Pharma
Kriam Pharma will focus on categories such as anti-diabetic, cardiac care, gastrointestinal, pain management, dermatology,…
AstraZeneca launches Eculizumab in India
It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquisition will be funded through the IPO proceeds raised by Senores. This is in line with the Objects of the IPO stated in…
Global pharma deal value rises to $18.3 billion in July 2025: GlobalData
Merck, Nordic Capital, and Sanofi drive 79 per cent of July’s total deal value as venture capital activity records a decline
Medistep Healthcare eyes ₹16.09 cr fundraise to acquire new plant & machinery
A significant portion of the IPO proceeds will be allocated toward the acquisition and installation of advanced equipment at the…
Startups: India’s next big bet on pharma innovation?
While India’s pharma startups can resolve scientific and systemic blind spots, funding remains the missing link blocking scalable…
India’s pharma funding reaches $294 million in July 2025
Pharma funding snapshot highlights late-stage dominance and surge in capital flow, with Meril’s $200M round leading July’s…
US-EU trade deal puts pharma industry at substantial fiscal risk: GlobalData
The imposition of tariffs threatens to elevate costs, creating uncertainty in launch planning, particularly for late-stage assets…
China’s obesity market forecasts rise with homegrown therapies and late-stage pipeline
With ten other drugs in Phase III development by domestic companies, according to GlobalData’s Pharmaceutical Intelligence Center,…
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024